Sign In
Register
eISSN:2278-5299

International Journal of Latest Research in Science and Technology

DOI:10.29111/ijlrst   ISRA Impact Factor:3.35,  Peer-reviewed, Open-access Journal

A News Letter Sign UP!
COMPUTATIONAL DRUG RE-POSITIONING: AN APPROACH TO DISCOVER NOVEL ANTIMALARIALS

Research Paper Open Access

International Journal of Latest Research in Science and Technology Vol.4 Issue 4, pp 119-127,Year 2015

COMPUTATIONAL DRUG RE-POSITIONING: AN APPROACH TO DISCOVER NOVEL ANTIMALARIALS

Yunusa, Abdulmajeed,Bello, shaibu Oricha,Chika, Aminu

Correspondence should be addressed to :

Received : 20 August 2015; Accepted : 25 August 2015 ; Published : 31 August 2015

Share
Download 125
View 178
Article No. 10553
Abstract

In this study molecular docking method was used to select potential inhibitors of the Plasmodium targets and the antimalarial activity of these inhibitors (drugs) was confirmed using Plasmodium berghei induced mice (in vivo). One hundred commercially available drugs not used for malaria were selected from DrugBank and the potential binding affinities of the selected drugs against the Plasmodium targets were analysed using molegro virtual docker software. Ten drugs with the best affinities (Fluconazole, indomethacin, loratidine, lisinopril, meloxicam, promethazine, nifedipine, clarithromycin, piroxicam and flucloxacillin) were selected and the antimalarial activity of these drugs were confirmed using Plasmodium berghei mice model. Nifedipine, clarithromycin, flucloxacillin and lisinopril produced significant suppressive, curative and prophylactic activity while meloxicam and piroxicam produced only significant suppressive and curative activity. All the tested drugs produced significant suppressive activity. Nifedipine, clarithromycin, flucloxacillin and lisinopril are therefore potential chemoprophylatic and chemothrerapeutic agents whilemeloxicam and piroxicam are potential chemotherapeutic agents.

Key Words   
Plasmodium berghei, Antimalarial, Computational repositioning;Mice.

Copyright
References
  1. Reyburn H. New WHO guidelines for the treatment of malaria. BMJ. 2010;340.
  2. Phyo AP, Nkhoma S, Stepniewska K, Ashley EA, Nair S, McGready R, et al. Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study. The Lancet. 2012;379(9830):1960-6.
  3. Aguiar ACC, da Rocha EM, de Souza NB, França TC, Krettli AU. New approaches in antimalarial drug discovery and development: a review. Memórias do Instituto Oswaldo Cruz. 2012;107(7):831-45.
  4. DiMasi JA, Hansen RW, Grabowski HG. The price of innovation: new estimates of drug development costs. Journal of health economics. 2003;22(2):151-85.
  5. Padhy B, Gupta Y. Drug repositioning: re-investigating existing drugs for new therapeutic indications. Journal of postgraduate medicine. 2011;57(2):153.
  6. Nsanzabana C, Rosenthal PJ. In vitro activity of antiretroviral drugs against Plasmodium falciparum. Antimicrobial agents and chemotherapy. 2011;55(11):5073-7.
  7. Li YY, An J, Jones SJ. A computational approach to finding novel targets for existing drugs. PLoS computational biology. 2011;7(9):e1002139.
  8. Penna-Coutinho J, Cortopassi WA, Oliveira AA, França TCC, Krettli AU. Antimalarial activity of potential inhibitors of Plasmodium falciparum lactate dehydrogenase enzyme selected by docking studies. PloS one. 2011;6(7):e21237.
  9. Reagan-Shaw S, Nihal M, Ahmad N. Dose translation from animal to human studies revisited. The FASEB Journal. 2008;22(3):659-61.
  10. Ryley J, Peters W. The antimalarial activity of some quinolone esters. Annals of tropical medicne and parasitology. 1970;64(2):209-22.
  11. Fidock DA, Rosenthal PJ, Croft SL, Brun R, Nwaka S. Antimalarial drug discovery: efficacy models for compound screening. Nature Reviews Drug Discovery. 2004;3(6):509-20.
  12. Ekland EH, Schneider J, Fidock DA. Identifying apicoplast-targeting antimalarials using high-throughput compatible approaches. The FASEB Journal. 2011;25(10):3583-93.
  13. Zhao X-J, Ishizaki T. The in vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes. Journal of pharmacology and Experimental Therapeutics. 1997;283(3):1168-76.
  14. Rasoanaivo P, Ratsimamanga-Urverg S, Frappier F. Reversing agents in the treatment of drug-resistant malaria. Current medicinal chemistry. 1996;3(1):1-10.
  15. Deharo E, Barkan D, Krugliak M, Golenser J, Ginsburg H. Potentiation of the antimalarial action of chloroquine in rodent malaria by drugs known to reduce cellular glutathione levels. Biochemical pharmacology. 2003;66(5):809-17.
  16. Oduola A, Sowunmi A, Milhous W, Brewer T, Kyle D, Gerena L, et al. In vitro and in vivo reversal of chloroquine resistance in Plasmodium falciparum with promethazine. The American journal of tropical medicine and hygiene. 1998;58(5):625-9.
To cite this article

Yunusa, Abdulmajeed,Bello, shaibu Oricha,Chika, Aminu , " Computational Drug Re-positioning: An Approach To Discover Novel Antimalarials ", International Journal of Latest Research in Science and Technology . Vol. 4, Issue 4, pp 119-127 , 2015

Responsive image

MNK Publication was founded in 2012 to upholder revolutionary ideas that would advance the research and practice of business and management. Today, we comply with to advance fresh thinking in latest scientific fields where we think we can make a real difference and growth now also including medical and social care, education,management and engineering.

Responsive image

We offers several opportunities for partnership and tie-up with individual, corporate and organizational level. We are working on the open access platform. Editors, authors, readers, librarians and conference organizer can work together. We are giving open opportunities to all. Our team is always willing to work and collaborate to promote open access publication.

Responsive image

Our Journals provide one of the strongest International open access platform for research communities. Our conference proceeding services provide conference organizers a privileged platform for publishing extended conference papers as journal publications. It is deliberated to disseminate scientific research and to establish long term International collaborations and partnerships with academic communities and conference organizers.